In the combination of different genotypes of KRAS, TP53, and APC, the TMB and immune score are significantly higher in wild type than KRAS/TP53/APC mutant type colon cancer (Supplement Figure 3). This evidence concerns the gene TP53 and malignant colon neoplasm.